3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Polycythemia Vera
2
Myeloproliferative Disorders
2
Lung Neoplasms
2
Tuberous Sclerosis
1
Smoking
1
Renal Insufficiency, Chronic
1
Pancreatitis, Chronic
1
Pancreatitis
1
Pancreatic Cyst
1
Non-alcoholic Fatty Liver Disease
1
Neoplasms
1
Multiple Sclerosis
1
Lymphangioleiomyomatosis
1
Liver Cirrhosis, Biliary
1
Lip Neoplasms
1
Irritable Bowel Syndrome
1
Inflammatory Bowel Diseases
1
Hepatitis
1
Head and Neck Neoplasms
1
Genetic Predisposition to Disease
1
Gastritis
1
Fibrosis
1
Exocrine Pancreatic Insufficiency
1
Endocrine Gland Neoplasms
1
Dyslipidemias
1
Diabetes Mellitus
1
Cystic Fibrosis
1
Crohn Disease
1
Chronic Pain
1
Chronic Disease
1
Interventions
Doxorubicin
5
pembrolizumab
4
Specimen Handling
4
Radiotherapy
4
Radiation
4
Nivolumab
4
Magnetic Resonance Spectroscopy
3
Ipilimumab
3
CTLA-4 Antigen
3
Biopsy
3
cabozantinib
2
Ifosfamide
2
tremelimumab
1
talimogene laherparepvec
1
regorafenib
1
peposertib
1
pazopanib
1
olaratumab
1
liposomal doxorubicin
1
futibatinib
1
fludarabine
1
eribulin
1
durvalumab
1
avelumab
1
aldesleukin
1
X-Rays
1
Trabectedin
1
Standard of Care
1
Quality of Life
1
Injections
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Histiocytoma, Malignant Fibrous
×
Phlebotomy
×
1 year
×
Clear all
No trials found.